To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene MED8andELOVL1TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
596 representative clones for gene MED8andELOVL1 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
AV686591 hepatocellular carcinoma .a 1 to 648 1 to 638   tiling clone,   638/638
(100 %)
9 diff
(98.6 %id)
AV696237 hepatocellular carcinoma .a 1 to 566 1 to 566       566/642
(88 %)
20 diff
(96.9 %id)
DB482953 hippocampus .a 1 to 505 1 to 505       505/505
(100 %)
1 diff
(99.9 %id)
AW960773   .a 22 to 725 1 to 706       706/706
(100 %)
13 diff
(98.2 %id)
BI822262 pooled brain, lung, testis .a 270 to 1141 1 to 869   tiling clone,   869/873
(99 %)
14 diff
(98.4 %id)
TI_57199093   .a 270 to 1141 65 to 933       869/937
(92 %)
20 diff
(97.9 %id)
CV023460 mixed .a 353 to 879 1 to 527       527/527
(100 %)
31 diff
(94.2 %id)
AW581932 stomach .a 358 to 884 532 to 6   tiling clone,   527/532
(99 %)
2 diff
(99.7 %id)
FN053996 breast carcinoma .a 433 to 516 1 to 84       84/84
(100 %)
0 diff
(100 %id)
BF378974 uterus .a 458 to 567 121 to 12       110/121
(90 %)
0 diff
(100 %id)
FN149020 breast carcinoma .a 610 to 684 1 to 75       75/75
(100 %)
3 diff
(96.0 %id)
AI287325 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .a 710 to 878 169 to 1       169/169
(100 %)
0 diff
(100 %id)
EC480493 Prostate .a 713 to 795 83 to 1       83/83
(100 %)
0 diff
(100 %id)
EC495235 Prostate .a 713 to 795 83 to 1       83/83
(100 %)
0 diff
(100 %id)
EC496057 Prostate .a 1024 to 1118 1 to 95   tiling clone,   95/95
(100 %)
0 diff
(100 %id)
BF569346 Kidney, renal carcinoma (ascites) .a 1056 to 1675 1 to 616   tiling clone, fully sequenced,   616/616
(100 %)
1 diff
(99.9 %id)
BE834350 ovary .a 1265 to 1818 554 to 3       552/566
(97 %)
5 diff
(99.2 %id)
BF570141 Kidney, renal carcinoma (ascites) .a 1645 to 2121 482 to 1   tiling clone, fully sequenced,   482/482
(100 %)
5 diff
(99.0 %id)
DA026913   .b 1 to 574 2 to 576   tiling clone, capped   575/575
(100 %)
4 diff
(99.4 %id)
DA472934   .b 2 to 565 2 to 566   tiling clone, capped   565/565
(100 %)
2 diff
(99.7 %id)
DA947877 Spleen .b 2 to 569 2 to 570   capped   569/569
(100 %)
1 diff
(99.9 %id)
DA574089   .b 9 to 554 2 to 547   capped   546/546
(100 %)
1 diff
(99.9 %id)
DA102465 cerebellum .b 38 to 547 2 to 511   capped   510/510
(100 %)
0 diff
(100 %id)
BG698122 skin .b 611 to 1514 1 to 909   tiling clone,   909/914
(99 %)
23 diff
(97.5 %id)
DB314805   .b 1502 to 2032 531 to 1   tiling clone,   531/531
(100 %)
1 diff
(99.9 %id)
NM_052877.3   .c 1 to 1486 1 to 1486 exact RefSeq, AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 1486/1486
(100 %)
0 diff
(100 %id)
AA345624 gall bladder .c 5 to 341 1 to 337   tiling clone,   337/338
(99 %)
1 diff
(99.8 %id)
BM826813 Ascites, stomach .c 5 to 335 1 to 332       332/332
(100 %)
2 diff
(99.4 %id)
AW963253   .c 6 to 694 1 to 690       690/691
(99 %)
10 diff
(98.6 %id)
CB995078 placenta, pre-eclamptic placenta .c 6 to 633 21 to 657       637/868
(73 %)
22 diff
(97.5 %id)
CB994699 placenta, pre-eclamptic placenta .c 6 to 458 21 to 471       451/555
(81 %)
9 diff
(98.4 %id)
BI560858 testis .c 8 to 708 1 to 701       701/701
(100 %)
4 diff
(99.5 %id)
BG715672 brain, hypothalamus .c 10 to 723 1 to 714       714/714
(100 %)
2 diff
(99.8 %id)
BG722462 testis .c 10 to 791 1 to 784       784/791
(99 %)
8 diff
(99.0 %id)
BG722466 testis .c 10 to 816 1 to 806       806/815
(98 %)
2 diff
(99.8 %id)
AA375723 lung .c 11 to 318 1 to 310       310/336
(92 %)
3 diff
(99.2 %id)
BF369993 prostate_normal .c 11 to 123 7 to 119       113/119
(94 %)
6 diff
(95.0 %id)
BG941052 blood .c 12 to 427 1 to 416       416/416
(100 %)
1 diff
(99.8 %id)
DN915962   .c 12 to 147 1 to 136       136/136
(100 %)
1 diff
(99.3 %id)
CB998835 Blood vessels - aorta, basilar and artery .c 12 to 318 1 to 308       308/661
(46 %)
7 diff
(99.0 %id)
BG943641 blood .c 13 to 443 1 to 431       431/431
(100 %)
2 diff
(99.6 %id)
DB447762 testis .c 13 to 459 1 to 446       446/452
(98 %)
2 diff
(99.6 %id)
DB474357 hippocampus .c 13 to 506 1 to 494       494/494
(100 %)
0 diff
(100 %id)
TI_44349094   .c 13 to 708 91 to 786       696/786
(88 %)
6 diff
(99.3 %id)
DB502933 hypothalamus .c 15 to 500 1 to 486       486/486
(100 %)
0 diff
(100 %id)
DB453050 testis .c 16 to 508 1 to 493       493/493
(100 %)
2 diff
(99.6 %id)
TI_57196213   .c 19 to 879 58 to 929       872/930
(93 %)
23 diff
(97.6 %id)
TI_44166776   .c 19 to 688 79 to 748       670/748
(89 %)
9 diff
(98.8 %id)
TI_44001138   .c 19 to 801 85 to 867       783/933
(83 %)
19 diff
(98.0 %id)
BI548755 brain, hippocampus .c 20 to 688 1 to 669       669/669
(100 %)
7 diff
(99.0 %id)
BI544729 brain, hippocampus .c 20 to 801 1 to 782       782/848
(92 %)
18 diff
(97.9 %id)
BI818434 pooled brain, lung, testis .c 22 to 879 1 to 869       869/870
(99 %)
17 diff
(98.1 %id)
CR995207 T-Lymphocytes .c 22 to 712 1 to 691       691/694
(99 %)
1 diff
(99.9 %id)
CR994153 T-Lymphocytes .c 22 to 866 1 to 844       844/844
(100 %)
6 diff
(99.3 %id)
TI_57216074   .c 23 to 773 23 to 782       760/783
(97 %)
24 diff
(97.0 %id)
CR975065 T-Lymphocytes .c 25 to 838 1 to 811       811/811
(100 %)
3 diff
(99.7 %id)
AW793173 uterus .c 26 to 321 1 to 295       295/295
(100 %)
1 diff
(99.7 %id)
BE544249 cervical carcinoma cell line, cervix .c 29 to 792 1 to 760       760/1080
(70 %)
17 diff
(98.5 %id)
BI753663 brain .c 31 to 773 1 to 752       752/753
(99 %)
15 diff
(98.1 %id)
CB216011 normal endometrium, late proliferativephase, cycle day 13, uterus .c 31 to 639 1 to 609       609/609
(100 %)
0 diff
(100 %id)
ES307620 beard hair, skin .c 36 to 229 1 to 193       193/193
(100 %)
6 diff
(96.9 %id)
BI753393 brain .c 36 to 768 2 to 733       732/733
(99 %)
8 diff
(99.0 %id)
BU166970 melanotic melanoma, skin .c 36 to 847 1 to 823       823/869
(94 %)
15 diff
(98.3 %id)
TI_57218235   .c 36 to 768 35 to 766       732/766
(95 %)
8 diff
(99.0 %id)
CD635332   .c 39 to 611 585 to 13       573/600
(95 %)
2 diff
(99.7 %id)
CD635333   .c 39 to 611 16 to 587       572/599
(95 %)
4 diff
(99.4 %id)
BE908898 epithelioid carcinoma, Pancreas .c 39 to 764 1 to 728       728/1046
(69 %)
12 diff
(98.9 %id)
BI914180 brain .c 40 to 707 1 to 668       668/670
(99 %)
2 diff
(99.8 %id)
CF552704 Pooled muscle (cardiac and skeletal) .c 40 to 855 1 to 822       822/849
(96 %)
12 diff
(98.6 %id)
BE866910 adenocarcinoma, colon .c 42 to 795 1 to 752       752/1079
(69 %)
16 diff
(98.6 %id)
TI_57242808   .c 42 to 707 31 to 696       666/698
(95 %)
1 diff
(99.9 %id)
AA094000   .c 43 to 324 1 to 281       281/288
(97 %)
5 diff
(98.3 %id)
BI488866 brain .c 45 to 852 1 to 809       809/838
(96 %)
8 diff
(99.1 %id)
TI_45379727   .c 45 to 852 94 to 902       809/931
(86 %)
8 diff
(99.2 %id)
BG165902 hypernephroma, cell line, Kidney .c 47 to 741 1 to 689       689/928
(74 %)
25 diff
(97.4 %id)
AF521562   .c 49 to 855 1 to 807       807/807
(100 %)
1 diff
(99.9 %id)
AV646977 corresponding non cancerous liver tissue .c 49 to 809 4 to 772     Submitted on the opposite strand 776/772
(100 %)
18 diff
(97.7 %id)
H26940 breast .c 49 to 459 1 to 416       415/416
(99 %)
15 diff
(96.4 %id)
AA223382 brain, neuroepithelial cells .c 49 to 500 4 to 466       472/466
(101 %)
58 diff
(87.6 %id)
BF246245 brain, glioblastoma .c 49 to 536 7 to 531       534/668
(79 %)
132 diff
(80.3 %id)
DB476447 hippocampus .c 50 to 511 26 to 487       465/487
(95 %)
41 diff
(91.6 %id)
R60110 whole brain .c 50 to 587 12 to 555     Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 548/557
(98 %)
26 diff
(95.4 %id)
BI765609 pooled colon, kidney, stomach .c 50 to 701 58 to 752       544/752
(72 %)
17 diff
(97.8 %id)
BI912869 brain .c 50 to 767 1 to 719       719/719
(100 %)
2 diff
(99.8 %id)
TI_57147031   .c 50 to 701 58 to 752       544/752
(72 %)
17 diff
(97.8 %id)
TI_57238138   .c 50 to 767 29 to 747       723/747
(96 %)
6 diff
(99.2 %id)
BE782220 eye, retinoblastoma .c 52 to 794 1 to 742       742/1043
(71 %)
19 diff
(98.2 %id)
BM802267 duodenal adenocarcinoma, cell line, small intestine .c 53 to 675 1 to 630       630/905
(69 %)
15 diff
(98.4 %id)
R34763 whole brain .c 54 to 441 1 to 394     Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 394/413
(95 %)
9 diff
(97.9 %id)
CN368281 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .c 57 to 640 1 to 584       584/584
(100 %)
3 diff
(99.5 %id)
BE894640 melanotic melanoma, skin .c 59 to 764 1 to 710       710/897
(79 %)
17 diff
(98.2 %id)
BP432540   .c 59 to 410 1 to 352       352/352
(100 %)
2 diff
(99.5 %id)
BC010543 Cervix, carcinoma .c 60 to 1486 1 to 1427   tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 1427/1427
(100 %)
0 diff
(100 %id)
BX473022   .c 67 to 512 1 to 447       447/447
(100 %)
2 diff
(99.6 %id)
BM458511 lymph, lymphoma, cell line .c 73 to 852 44 to 835       792/1161
(68 %)
27 diff
(97.7 %id)
BE549120 cervical carcinoma cell line, cervix .c 80 to 805 1 to 721   available from MGC,   721/891
(80 %)
18 diff
(98.0 %id)
AW805094 uterus .c 96 to 243 9 to 157       149/157
(94 %)
6 diff
(96.2 %id)
T77678 whole brain .c 104 to 534 1 to 433       435/440
(98 %)
8 diff
(98.2 %id)
DN990177 brain, whole brain .c 120 to 845 1 to 726       726/726
(100 %)
6 diff
(99.2 %id)
BM769202 stomach .c 135 to 663 1 to 529       529/529
(100 %)
0 diff
(100 %id)
BM823359 stomach .c 135 to 591 1 to 457       457/457
(100 %)
16 diff
(96.5 %id)
BM825704 stomach .c 135 to 567 1 to 433       433/433
(100 %)
1 diff
(99.8 %id)
FN174447 breast carcinoma .c 144 to 234 1 to 92       89/92
(96 %)
2 diff
(97.9 %id)
BI489563 brain .c 148 to 752 92 to 699       608/699
(86 %)
12 diff
(98.3 %id)
TI_45379729   .c 148 to 752 92 to 699       608/699
(86 %)
12 diff
(98.3 %id)
BQ353983 head_neck .c 173 to 394 83 to 304       223/304
(73 %)
6 diff
(98.1 %id)
BM826895 stomach .c 210 to 346 1 to 137       137/137
(100 %)
2 diff
(98.6 %id)
AA037068 senescent fibroblast .c 211 to 643 1 to 439       439/439
(100 %)
6 diff
(98.7 %id)
AW387829 stomach .c 213 to 823 622 to 14       609/627
(97 %)
6 diff
(99.1 %id)
AW387868 stomach .c 213 to 853 634 to 1       634/635
(99 %)
17 diff
(97.4 %id)
AW387870 stomach .c 222 to 864 651 to 7       645/651
(99 %)
9 diff
(98.7 %id)
AW387886 stomach .c 240 to 860 645 to 26       620/647
(95 %)
7 diff
(99.0 %id)
BE272485 Kidney, renal cell adenocarcinoma .c 285 to 827 1 to 543       543/543
(100 %)
0 diff
(100 %id)
CR735204 astrocytoma grade IV, cell line, brain .c 294 to 798 41 to 545       505/545
(92 %)
6 diff
(98.9 %id)
FN055019 breast carcinoma .c 305 to 403 1 to 100       100/100
(100 %)
3 diff
(97.0 %id)
TI_1948099763   .c 318 to 572 137 to 391   fully sequenced,   255/284
(89 %)
6 diff
(97.9 %id)
TI_1948099933   .c 318 to 572 131 to 384   fully sequenced,   253/283
(89 %)
10 diff
(96.5 %id)
TI_1948100106   .c 318 to 610 139 to 431   fully sequenced,   293/324
(90 %)
7 diff
(97.9 %id)
TI_1948100280   .c 318 to 801 134 to 617   fully sequenced,   484/515
(93 %)
6 diff
(98.9 %id)
BM808593 brain, hippocampus .c 495 to 1377 13 to 904       892/1025
(87 %)
17 diff
(98.4 %id)
TI_1948099764   .c 511 to 953 571 to 129   fully sequenced,   443/571
(77 %)
0 diff
(100 %id)
TI_1948099934   .c 511 to 953 574 to 130   fully sequenced,   445/472
(94 %)
0 diff
(100 %id)
AI547308 Prostate .c 577 to 1325 1 to 751       751/751
(100 %)
10 diff
(98.7 %id)
TI_1948100107   .c 580 to 953 505 to 131   fully sequenced,   375/505
(74 %)
1 diff
(99.9 %id)
TI_1948100281   .c 760 to 953 324 to 128   fully sequenced,   197/324
(60 %)
0 diff
(100 %id)
R60048 whole brain .c 882 to 1486 610 to 11   AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 600/603
(99 %)
30 diff
(95.1 %id)
BI035771 nervous_tumor .c 916 to 1225 309 to 1       309/309
(100 %)
6 diff
(98.1 %id)
AA223282 brain, neuroepithelial cells .c 998 to 1486 489 to 1       489/489
(100 %)
5 diff
(99.0 %id)
AA094855   .c 1032 to 1243 1 to 206       206/206
(100 %)
13 diff
(93.7 %id)
R49637 whole brain .c 1071 to 1486 443 to 11   AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 433/436
(99 %)
25 diff
(94.3 %id)
BC010019 Skin, melanotic melanoma. .d 1 to 1185 1 to 1185 exact tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 1185/1185
(100 %)
0 diff
(100 %id)
BE302807 melanotic melanoma, skin .d 2 to 444 1 to 444       444/444
(100 %)
8 diff
(98.2 %id)
AA337371 endometrium .d 17 to 205 1 to 189       189/189
(100 %)
0 diff
(100 %id)
CR622379 T cells (Jurkat cell line) Cot10-normalized .d 22 to 1943 1 to 1861       1861/1861
(100 %)
0 diff
(100 %id)
AL559029 T cells from T cell leukemia .d 22 to 1036 1 to 954       954/954
(100 %)
1 diff
(99.9 %id)
BQ669255 epidermoid carcinoma, cell line, salivary gland .d 211 to 975 1 to 773       773/958
(80 %)
12 diff
(98.8 %id)
CA311066 Human Lung Epithelial cells, lung .d 223 to 990 784 to 17   AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 768/768
(100 %)
1 diff
(99.9 %id)
BG744847 blood, natural killer cells, cell line .d 233 to 1057 847 to 23       825/847
(97 %)
1 diff
(99.9 %id)
TI_159683943   .d 254 to 1185 1017 to 92   AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 928/1037
(89 %)
18 diff
(98.3 %id)
BE870291 adenocarcinoma, colon .d 256 to 986 1 to 727       727/797
(91 %)
15 diff
(98.2 %id)
BM706150 eye, lens .d 259 to 931 1 to 673       673/673
(100 %)
3 diff
(99.6 %id)
AW387776 stomach .d 280 to 888 611 to 5       607/611
(99 %)
3 diff
(99.6 %id)
BQ574506 Chondrosarcoma Grade II, Left Pelvis .d 285 to 990 723 to 19   AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 705/705
(100 %)
1 diff
(99.9 %id)
CA307454 Alveolar Macrophage, lung .d 285 to 986 719 to 19   AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 701/701
(100 %)
1 diff
(99.9 %id)
AW387788 stomach .d 294 to 875 597 to 18       580/600
(96 %)
5 diff
(99.2 %id)
TI_149301949   .d 297 to 1129 907 to 77   AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 831/963
(86 %)
13 diff
(98.7 %id)
BE272566 Kidney, renal cell adenocarcinoma .d 300 to 888 1 to 588       588/588
(100 %)
1 diff
(99.9 %id)
BE387672 endometrium, adenocarcinoma cell line, uterus .d 305 to 902 1 to 598       598/598
(100 %)
0 diff
(100 %id)
BM562710 astrocytoma grade IV, cell line, brain .d 309 to 1259 1 to 958       958/1058
(90 %)
13 diff
(98.8 %id)
TI_154107195   .d 363 to 1129 859 to 95   AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 765/939
(81 %)
26 diff
(97.3 %id)
BQ021748 lung, Metastatic Chondrosarcoma .d 374 to 983 628 to 19   AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 610/610
(100 %)
0 diff
(100 %id)
CA425829 cell lines, Chondrosarcoma .d 381 to 1187 823 to 17   AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 807/807
(100 %)
1 diff
(99.9 %id)
BQ218726 leiomyosarcoma, uterus .d 395 to 1185 13 to 803   AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 791/803
(98 %)
7 diff
(99.2 %id)
BU618140 Bone, Subchondral Bone .d 396 to 990 613 to 19   AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 595/595
(100 %)
0 diff
(100 %id)
BM998317 lung, Metastatic Chondrosarcoma .d 405 to 986 600 to 19   AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 582/610
(95 %)
0 diff
(100 %id)
CB850932 lung, Primary Lung Cystic Fibrosis EpithelialCells .d 417 to 1129 732 to 19   AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 714/714
(100 %)
1 diff
(99.9 %id)
BU736916 eye, lens .d 445 to 1129 704 to 19   AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 686/686
(100 %)
1 diff
(99.9 %id)
BX391890   .d 472 to 1217 747 to 1       747/889
(84 %)
15 diff
(98.4 %id)
BM823298 Ascites, stomach .d 511 to 1093 1 to 583       583/583
(100 %)
0 diff
(100 %id)
DB551814 hippocampus .d 518 to 986 1 to 469     Submitted on the opposite strand 469/469
(100 %)
0 diff
(100 %id)
BQ027159 lung, Metastatic Chondrosarcoma .d 519 to 1185 682 to 17   AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 666/666
(100 %)
2 diff
(99.7 %id)
BQ001277 lung, Metastatic Chondrosarcoma .d 532 to 1129 617 to 19   AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 599/606
(98 %)
2 diff
(99.7 %id)
CA446962 Chondrosarcoma, Left Pubic Bone .d 533 to 1129 617 to 19   AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 599/599
(100 %)
2 diff
(99.7 %id)
BM693359 eye, Retina Foveal and Macular .d 557 to 932 1 to 376   fully sequenced, Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 376/376
(100 %)
0 diff
(100 %id)
BQ030196 lung, Metastatic Chondrosarcoma .d 572 to 986 433 to 19   AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 415/415
(100 %)
0 diff
(100 %id)
AA147608 uterus .d 573 to 1153 1 to 577       577/578
(99 %)
13 diff
(97.8 %id)
BG289617 bladder, transitional cell papilloma, cell line .d 592 to 1333 1 to 745       745/863
(86 %)
22 diff
(97.5 %id)
AI369656 anaplastic oligodendroglioma, brain .d 597 to 993 400 to 4       397/400
(99 %)
0 diff
(100 %id)
TI_154094488   .d 601 to 1185 709 to 120   AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 590/713
(82 %)
17 diff
(97.7 %id)
CD556863 brain, Pituitary .d 605 to 1022 1 to 422       422/1004
(42 %)
11 diff
(99.0 %id)
BQ677287 melanotic melanoma, cell line, skin .d 619 to 1462 1 to 854       854/972
(87 %)
34 diff
(96.6 %id)
BU838268 melanotic melanoma, cell line, skin .d 620 to 1385 1 to 774       774/874
(88 %)
16 diff
(98.2 %id)
TI_57197370   .d 622 to 1069 79 to 531       453/953
(47 %)
15 diff
(98.5 %id)
BI819482 pooled brain, lung, testis .d 623 to 1069 1 to 452       452/874
(51 %)
9 diff
(99.0 %id)
BF036784 adenocarcinoma, ovary .d 630 to 1032 1 to 405       405/408
(99 %)
3 diff
(99.3 %id)
BQ446014 Knee, Osteoarthritic Cartilage .d 637 to 1185 565 to 17   AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 549/549
(100 %)
1 diff
(99.9 %id)
BM006562 ductal carcinoma, cell line, Pancreas .d 639 to 1132 1 to 492   fully sequenced,   492/492
(100 %)
4 diff
(99.2 %id)
TI_59395654   .d 640 to 1132 113 to 603   fully sequenced,   491/491
(100 %)
3 diff
(99.4 %id)
AW027143 thymus, pooled .d 652 to 1185 535 to 1       535/535
(100 %)
2 diff
(99.7 %id)
AI761316 colon, colon tumor, RER+ .d 671 to 1129 460 to 1       460/460
(100 %)
3 diff
(99.4 %id)
BQ369128 placenta_normal .d 672 to 1046 391 to 20       372/391
(95 %)
3 diff
(99.3 %id)
BQ011155 placenta .d 673 to 1129 475 to 19   AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 457/457
(100 %)
0 diff
(100 %id)
BU570738 testis .d 679 to 1538 1 to 865       865/893
(96 %)
17 diff
(98.1 %id)
BM992246 Bone, Subchondral Bone .d 682 to 1185 522 to 19   AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 504/504
(100 %)
1 diff
(99.9 %id)
DB518534 testis .d 688 to 1146 1 to 458   AAA Submitted on the opposite strand 458/458
(100 %)
2 diff
(99.6 %id)
AA554428 breast .d 691 to 1132 441 to 1       441/441
(100 %)
2 diff
(99.6 %id)
C01657   .d 699 to 980 1 to 283       283/283
(100 %)
3 diff
(99.0 %id)
AA756997   .d 706 to 1132 428 to 2       427/428
(99 %)
1 diff
(99.8 %id)
BE328199 carcinoid, lung .d 706 to 1132 427 to 1       427/427
(100 %)
0 diff
(100 %id)
AI394319 B-cell, chronic lymphotic leukemia .d 713 to 1146 434 to 1       434/434
(100 %)
0 diff
(100 %id)
AI025595   .d 721 to 1132 413 to 3       411/413
(99 %)
0 diff
(100 %id)
BG291953 bladder, transitional cell papilloma, cell line .d 725 to 1431 1 to 707       707/831
(85 %)
8 diff
(99.1 %id)
AI138246   .d 727 to 1132 408 to 3       406/408
(99 %)
0 diff
(100 %id)
AA662369 normal prostate, Prostate .d 733 to 1136 404 to 1       404/404
(100 %)
0 diff
(100 %id)
BM852985 Ascites, stomach .d 736 to 1201 1 to 466       466/472
(98 %)
2 diff
(99.6 %id)
AA421957 ovarian tumor, ovary .d 738 to 1129 1 to 392   AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 392/392
(100 %)
5 diff
(98.8 %id)
F31100 pectoral muscle (after mastectomy) .d 744 to 1129 1 to 386   AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 386/386
(100 %)
1 diff
(99.8 %id)
BG980105 colon_normal .d 745 to 911 178 to 12       167/181
(92 %)
2 diff
(98.9 %id)
AI128521 placenta .d 760 to 1185 446 to 21   AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 426/426
(100 %)
3 diff
(99.3 %id)
AI205948 Kidney .d 760 to 1185 426 to 1       426/426
(100 %)
0 diff
(100 %id)
AI589587 anaplastic oligodendroglioma, brain .d 760 to 1186 447 to 21       427/447
(95 %)
0 diff
(100 %id)
DB512905 testis .d 764 to 1185 1 to 422     Submitted on the opposite strand 422/422
(100 %)
4 diff
(99.1 %id)
CA436526 Bone, Subchondral Bone .d 781 to 1185 423 to 19   AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 405/405
(100 %)
1 diff
(99.8 %id)
AA482416 ovarian tumor, ovary .d 790 to 1120 1 to 331   fully sequenced, Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 331/331
(100 %)
0 diff
(100 %id)
BG941053 blood .d 791 to 1132 370 to 28       343/370
(92 %)
0 diff
(100 %id)
AA291089 ovarian tumor, ovary .d 797 to 1122 9 to 335       327/335
(97 %)
6 diff
(98.3 %id)
BQ011650 placenta .d 803 to 1129 345 to 19   AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 327/327
(100 %)
0 diff
(100 %id)
BM463041 melanotic melanoma, skin .d 805 to 1188 171 to 554       384/1034
(37 %)
1 diff
(100.0 %id)
AI523523 aorta .d 825 to 1184 362 to 3       360/362
(99 %)
0 diff
(100 %id)
AA041286 heart .d 831 to 1129 301 to 1       301/301
(100 %)
4 diff
(98.7 %id)
BG111659 Bone, osteosarcoma, cell line .d 852 to 1640 1 to 781       781/945
(82 %)
27 diff
(97.2 %id)
BM668633 eye, Retina Foveal and Macular .d 902 to 1129 246 to 19   fully sequenced, AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 228/228
(100 %)
0 diff
(100 %id)
AW611661 Kidney .d 912 to 1199 293 to 1       293/298
(98 %)
11 diff
(96.4 %id)
R34431 whole brain .d 926 to 1360 1 to 449     Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 449/451
(99 %)
21 diff
(95.4 %id)
BU734663 eye, lens .d 935 to 1129 213 to 19   AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 195/195
(100 %)
0 diff
(100 %id)
AL580736 T cells from T cell leukemia .d 941 to 1876 995 to 67       929/995
(93 %)
0 diff
(100 %id)
DT217622 brain .d 957 to 1423 94 to 560       467/560
(83 %)
6 diff
(99.0 %id)
BG492676 lung, mucoepidermoid carcinoma .d 958 to 1701 1 to 761       761/766
(99 %)
41 diff
(94.7 %id)
BP262729 small intestine .d 978 to 1560 1 to 582       582/582
(100 %)
1 diff
(99.9 %id)
BP262799 small intestine .d 978 to 1561 1 to 584       584/584
(100 %)
5 diff
(99.2 %id)
AW842362 colon_normal .d 1008 to 1502 11 to 505       495/505
(98 %)
6 diff
(98.9 %id)
AA029835 uterus .d 1015 to 1558 1 to 546   fully sequenced,   546/546
(100 %)
2 diff
(99.7 %id)
BG026555 Bone, osteosarcoma, cell line .d 1027 to 1749 12 to 720       709/909
(77 %)
22 diff
(97.6 %id)
R20450 whole brain .d 1033 to 1248 1 to 217     Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 217/217
(100 %)
4 diff
(98.2 %id)
H64322 liver and spleen .d 1033 to 1354 1 to 324       324/330
(98 %)
2 diff
(99.4 %id)
AA482564 ovarian tumor, ovary .d 1034 to 1124 111 to 22   fully sequenced, AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 90/90
(100 %)
0 diff
(100 %id)
H67835 liver and spleen .d 1035 to 1536 1 to 505       505/505
(100 %)
22 diff
(95.7 %id)
BM006997 ductal carcinoma, cell line, Pancreas .d 1054 to 1084 32 to 1   fully sequenced,   32/32
(100 %)
8 diff
(75.0 %id)
TI_59395655   .d 1054 to 1084 32 to 1   fully sequenced,   32/32
(100 %)
8 diff
(75.0 %id)
BE719952 head_neck .d 1065 to 1281 10 to 225       216/225
(96 %)
6 diff
(97.4 %id)
CN368280 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .d 1108 to 1673 1 to 566       566/566
(100 %)
1 diff
(99.9 %id)
AW866426 stomach_normal .d 1112 to 1659 13 to 559       547/559
(97 %)
6 diff
(99.0 %id)
CB161514 Liver .d 1116 to 1646 1 to 531       531/531
(100 %)
0 diff
(100 %id)
CB162354 Liver .d 1116 to 1698 1 to 583       583/583
(100 %)
1 diff
(99.9 %id)
EC562627 Prostate .d 1123 to 1227 105 to 1       105/105
(100 %)
0 diff
(100 %id)
BG573202 placenta .d 1129 to 1684 1 to 557       557/558
(99 %)
3 diff
(99.5 %id)
FN116900 breast carcinoma .d 1156 to 1230 75 to 2     Submitted on the opposite strand 74/76
(97 %)
0 diff
(100 %id)
AW466959 2 pooled tumors (clear cell type), Kidney .d 1183 to 1551 372 to 4       369/372
(99 %)
0 diff
(100 %id)
BI862116 breast, mammary adenocarcinoma, cell line .d 1184 to 1990 15 to 823   tiling clone,   809/843
(95 %)
10 diff
(98.9 %id)
TI_57193455   .d 1184 to 1990 63 to 871       809/911
(88 %)
10 diff
(99.0 %id)
AA127574 lung, lung carcinoma .d 1275 to 1635 1 to 361   fully sequenced,   361/361
(100 %)
3 diff
(99.2 %id)
BQ181765 Knee, Osteoarthritic Cartilage .d 1311 to 1994 702 to 19   AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 684/684
(100 %)
2 diff
(99.8 %id)
TI_149279357   .d 1322 to 1994 753 to 82   AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 672/672
(100 %)
2 diff
(99.8 %id)
FN111684 breast carcinoma .d 1336 to 1431 97 to 1     Submitted on the opposite strand 97/98
(98 %)
1 diff
(99.0 %id)
BM969534 lung, Primary Lung Epithelial Cells .d 1344 to 1994 669 to 19   AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 651/651
(100 %)
1 diff
(99.9 %id)
W57558 heart .d 1362 to 1947 1 to 577       577/577
(100 %)
16 diff
(97.3 %id)
BU532813 mixed (pool of 40 RNAs) .d 1376 to 1945 1 to 575       575/722
(79 %)
21 diff
(97.1 %id)
BG898259 cartilage .d 1390 to 1885 87 to 582       496/513
(96 %)
6 diff
(98.9 %id)
BQ017244 lung, Metastatic Chondrosarcoma .d 1396 to 1994 617 to 19   AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 599/599
(100 %)
1 diff
(99.9 %id)
BG230758 blood, lymphocyte .d 1435 to 1994 560 to 1       560/560
(100 %)
0 diff
(100 %id)
BM694300 eye, RPE and Choroid .d 1444 to 1994 1 to 551   AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 551/551
(100 %)
3 diff
(99.5 %id)
TI_151705225   .d 1444 to 1994 625 to 75   AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 551/953
(57 %)
2 diff
(99.8 %id)
AW169086 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .d 1453 to 1994 542 to 1       542/542
(100 %)
1 diff
(99.9 %id)
BG054823 brain, glioblastoma (pooled) .d 1457 to 1994 538 to 1       538/538
(100 %)
0 diff
(100 %id)
AI188078   .d 1463 to 1995 535 to 3       533/535
(99 %)
0 diff
(100 %id)
CD521841 pooled .d 1483 to 1992 1 to 509       509/897
(56 %)
5 diff
(99.5 %id)
W56728 heart .d 1486 to 1650 8 to 182   fully sequenced,   175/182
(96 %)
7 diff
(96.2 %id)
H05262 whole brain .d 1491 to 1993 500 to 9       492/505
(97 %)
0 diff
(100 %id)
AW117546 pooled .d 1492 to 1994 503 to 1       503/503
(100 %)
2 diff
(99.7 %id)
BE047324 ovary, serous papillary tumor .d 1492 to 2001 514 to 5       510/514
(99 %)
0 diff
(100 %id)
BF196855 brain, glioblastoma (pooled) .d 1511 to 2004 497 to 4   tiling clone,   494/497
(99 %)
0 diff
(100 %id)
BQ005527 Chondrosarcoma, Left Pelvis .d 1517 to 1994 496 to 19   AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 478/478
(100 %)
6 diff
(98.8 %id)
AI741198 pooled .d 1524 to 1995 476 to 5       472/476
(99 %)
0 diff
(100 %id)
BF372291 prostate_tumor .d 1526 to 1958 442 to 9       434/442
(98 %)
0 diff
(100 %id)
DB543176 hippocampus .d 1527 to 1994 1 to 468     Submitted on the opposite strand 468/468
(100 %)
2 diff
(99.6 %id)
DB545198 hippocampus .d 1527 to 1992 1 to 466     Submitted on the opposite strand 466/469
(99 %)
2 diff
(99.6 %id)
AA029295 uterus .d 1528 to 1995 467 to 2   fully sequenced,   466/467
(99 %)
0 diff
(100 %id)
DB574112 hypothalamus .d 1529 to 1994 1 to 466     Submitted on the opposite strand 466/466
(100 %)
2 diff
(99.6 %id)
BE222838 brain, oligodendroglioma .d 1536 to 1995 461 to 2       460/493
(93 %)
0 diff
(100 %id)
H98639 melanocyte .d 1544 to 1994 450 to 1       450/450
(100 %)
5 diff
(98.9 %id)
H64323 liver and spleen .d 1545 to 1987 444 to 1       444/447
(99 %)
7 diff
(98.5 %id)
AI861991 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .d 1553 to 1994 442 to 1       442/442
(100 %)
0 diff
(100 %id)
BQ001923 lung, Metastatic Chondrosarcoma .d 1561 to 2000 452 to 19   AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 434/434
(100 %)
4 diff
(99.1 %id)
CA443270 lung, Metastatic Chondrosarcoma .d 1561 to 2000 452 to 19   AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 434/434
(100 %)
4 diff
(99.1 %id)
AI346012 adenocarcinoma, colon .d 1566 to 1995 431 to 2       430/431
(99 %)
0 diff
(100 %id)
BM703350 eye, human retina .d 1567 to 1994 1 to 428   fully sequenced, AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 428/428
(100 %)
0 diff
(100 %id)
AA147616 uterus .d 1570 to 1994 424 to 1       424/425
(99 %)
5 diff
(98.9 %id)
AI906386 breast .d 1574 to 1953 1 to 380       380/707
(53 %)
5 diff
(99.3 %id)
R48964 whole brain .d 1576 to 1994 444 to 11   AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 434/500
(86 %)
26 diff
(94.8 %id)
AW072074 pooled .d 1577 to 1996 425 to 6       420/425
(98 %)
0 diff
(100 %id)
AI049852   .d 1590 to 1995 412 to 7       406/412
(98 %)
0 diff
(100 %id)
AI937618 anaplastic oligodendroglioma, brain .d 1590 to 1994 420 to 16   AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 405/405
(100 %)
1 diff
(99.8 %id)
AA127392 lung, lung carcinoma .d 1605 to 2005 405 to 1   fully sequenced,   405/405
(100 %)
10 diff
(97.6 %id)
H68106 liver and spleen .d 1613 to 1989 389 to 1       389/389
(100 %)
19 diff
(95.2 %id)
W56775 heart .d 1620 to 1999 381 to 1   fully sequenced,   381/381
(100 %)
2 diff
(99.5 %id)
F37308 pectoral muscle (after mastectomy) .d 1629 to 1988 1 to 360       360/360
(100 %)
1 diff
(99.8 %id)
AI277076 adenocarcinoma, colon .d 1638 to 1995 359 to 2       358/359
(99 %)
0 diff
(100 %id)
F27368 pectoral muscle (after mastectomy) .d 1640 to 1885 1 to 246       246/246
(100 %)
0 diff
(100 %id)
AW149293 Kidney, renal cell tumor .d 1662 to 1994 336 to 1       336/336
(100 %)
5 diff
(98.6 %id)
AI290238 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .d 1700 to 2004 323 to 19   AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 305/305
(100 %)
1 diff
(99.7 %id)
R44153 whole brain .d 1717 to 1994 291 to 11   AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 281/285
(98 %)
5 diff
(98.3 %id)
FN046799 breast carcinoma .d 1760 to 1835 1 to 77       77/83
(92 %)
2 diff
(97.6 %id)
Z38737 brain, total brain .d 1772 to 1994 223 to 1       223/223
(100 %)
0 diff
(100 %id)
AA873092 2 pooled tumors (clear cell type), Kidney .d 1796 to 1994 214 to 17   AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 198/198
(100 %)
1 diff
(99.5 %id)
BM664815 eye, human retina .d 1813 to 1994 200 to 19   fully sequenced, AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 182/182
(100 %)
0 diff
(100 %id)
EC442122 Prostate .d 1822 to 1933 10 to 121       112/121
(92 %)
6 diff
(95.1 %id)
EC457044 Prostate .d 1827 to 1933 16 to 119       104/119
(87 %)
6 diff
(95.0 %id)
FN113782 breast carcinoma .d 1876 to 1964 12 to 98       87/101
(86 %)
9 diff
(91.1 %id)
EH351858   .d 1929 to 1995 1 to 67       67/80
(83 %)
1 diff
(98.8 %id)
AA205241   .e 1 to 460 9 to 474   tiling clone,   474/474
(100 %)
9 diff
(98.2 %id)
AA205169   .e 1865 to 1987 123 to 1   tiling clone,   123/123
(100 %)
0 diff
(100 %id)
AK298163   .f -8 to 1375 1 to 1384 exact tiling clone,   1384/1384
(100 %)
1 diff
(100.0 %id)
DC360315   .f -8 to 518 1 to 527       527/527
(100 %)
1 diff
(99.9 %id)
BE386334 melanotic melanoma, skin .f 16 to 480 1 to 465       465/465
(100 %)
0 diff
(100 %id)
NM_201542.3   .g 1 to 1170 1 to 1170 exact RefSeq, AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 1170/1170
(100 %)
0 diff
(100 %id)
CD555914 embryonic trophoblasts, made from WA01 stemcells .g 13 to 930 17 to 946   tiling clone,   930/1016
(91 %)
30 diff
(97.1 %id)
CA867436 Pancreas, Purified pancreatic islet .g 25 to 638 11 to 624       614/624
(98 %)
6 diff
(99.1 %id)
AA169516   .g 29 to 459 1 to 453       374/455
(82 %)
20 diff
(95.7 %id)
BU553636 ovary, teratocarcinoma, cell line .g 32 to 903 1 to 878       878/880
(99 %)
15 diff
(98.3 %id)
BQ053144 blood, natural killer cells, cell line .g 35 to 1032 1 to 1007       1007/1076
(93 %)
16 diff
(98.6 %id)
BM924522 pooled colon, kidney, stomach .g 40 to 951 1 to 925       925/1003
(92 %)
26 diff
(97.5 %id)
T86784 liver and spleen .g 50 to 543 1 to 499       499/516
(96 %)
12 diff
(97.7 %id)
BM466260 eye, retinoblastoma .g 52 to 988 1 to 951       951/1044
(91 %)
23 diff
(97.8 %id)
BM806322 leiomyosarcoma, uterus .g 65 to 1108 24 to 1079   tiling clone,   1056/1083
(97 %)
41 diff
(96.3 %id)
R09374 liver and spleen .g 67 to 423 1 to 361       361/365
(98 %)
8 diff
(97.9 %id)
R09375 liver and spleen .g 647 to 960 316 to 1       316/316
(100 %)
3 diff
(99.1 %id)
CA943454 Pancreas, Purified pancreatic islet .g 663 to 1113 451 to 1   tiling clone,   451/451
(100 %)
0 diff
(100 %id)
T86690 liver and spleen .g 790 to 1098 327 to 1       327/376
(86 %)
18 diff
(95.3 %id)
AA169464   .g 855 to 1171 316 to 1   tiling clone,   316/316
(100 %)
2 diff
(99.4 %id)
CR746457 melanotic melanoma, skin .h 1 to 462 28 to 489   tiling clone,   468/489
(95 %)
6 diff
(98.8 %id)
TI_151798557   .h 393 to 955 111 to 673   tiling clone,   563/713
(78 %)
13 diff
(98.2 %id)
BX116318 carcinoid, lung .h 847 to 1326 1 to 480   tiling clone,   480/480
(100 %)
0 diff
(100 %id)
BE670288 carcinoid, lung .h 888 to 1358 471 to 1       471/471
(100 %)
0 diff
(100 %id)
AI887871 carcinoid, lung .h 908 to 1354 447 to 1       447/447
(100 %)
0 diff
(100 %id)
AW294614   .h 932 to 1355 439 to 16   AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 424/434
(97 %)
0 diff
(100 %id)
BM714665 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .h 959 to 1355 1 to 397   fully sequenced, AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 397/397
(100 %)
0 diff
(100 %id)
BU739295 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .h 1280 to 1371 92 to 1   tiling clone, fully sequenced, Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 92/92
(100 %)
2 diff
(97.9 %id)
BG177442 lymph, lymphoma, cell line .i 1 to 721 1 to 721   tiling clone,   721/931
(77 %)
16 diff
(98.3 %id)
BU168625 ductal carcinoma, cell line, Pancreas .i 122 to 868 1 to 754       754/901
(83 %)
25 diff
(97.3 %id)
BU185747 ductal carcinoma, cell line, Pancreas .i 122 to 816 1 to 698       698/878
(79 %)
7 diff
(99.3 %id)
BU163168 ductal carcinoma, cell line, Pancreas .i 122 to 930 1 to 816       816/873
(93 %)
15 diff
(98.3 %id)
BU145409 ductal carcinoma, cell line, Pancreas .i 122 to 997 1 to 885       885/886
(99 %)
12 diff
(98.7 %id)
BQ689174 ductal carcinoma, cell line, Pancreas .i 122 to 719 1 to 598       598/924
(64 %)
9 diff
(99.1 %id)
BQ691919 ductal carcinoma, cell line, Pancreas .i 122 to 950 1 to 829       829/862
(96 %)
5 diff
(99.5 %id)
BQ690385 ductal carcinoma, cell line, Pancreas .i 122 to 895 1 to 786       786/864
(90 %)
14 diff
(98.4 %id)
BQ687894 ductal carcinoma, cell line, Pancreas .i 122 to 960 1 to 846       846/894
(94 %)
11 diff
(98.8 %id)
BG674851 skin .i 253 to 1077 1 to 842       842/954
(88 %)
34 diff
(96.5 %id)
BG696585 skin .i 254 to 1046 1 to 794   tiling clone,   794/794
(100 %)
10 diff
(98.8 %id)
BG739942 skin .i 269 to 1147 1 to 872   tiling clone,   872/877
(99 %)
27 diff
(97.0 %id)
BG741499 skin .i 270 to 1107 1 to 847   tiling clone,   847/849
(99 %)
28 diff
(96.8 %id)
BG740001 skin .i 273 to 1133 1 to 860       860/920
(93 %)
23 diff
(97.5 %id)
BG698707 skin .i 298 to 1215 1 to 924 G21A Y22T P23L L24* tiling clone,   924/926
(99 %)
18 diff
(98.1 %id)
BG740706 skin .i 300 to 1157 1 to 858   tiling clone,   858/858
(100 %)
9 diff
(99.0 %id)
CR598270 fetal liver .j 1 to 1581 1 to 1581 exact tiling clone,   1581/1581
(100 %)
0 diff
(100 %id)
BX405591 fetal liver, Liver .j 1 to 721 1 to 721   fully sequenced,   721/721
(100 %)
2 diff
(99.8 %id)
BP331251 rectum .j 151 to 746 1 to 596       596/596
(100 %)
1 diff
(99.9 %id)
BP353925   .j 151 to 725 1 to 575       575/581
(98 %)
2 diff
(99.7 %id)
BM828602 Ascites, stomach .j 157 to 369 1 to 214       214/214
(100 %)
6 diff
(97.2 %id)
BG742335 skin .j 168 to 733 1 to 565       565/565
(100 %)
1 diff
(99.9 %id)
BE393228 endometrium, adenocarcinoma cell line, uterus .j 194 to 861 1 to 664       664/672
(98 %)
18 diff
(97.4 %id)
BX405590 fetal liver, Liver .j 691 to 1581 891 to 1   fully sequenced,   891/891
(100 %)
5 diff
(99.5 %id)
CB149715 Liver .k 1 to 447 1 to 447       447/447
(100 %)
5 diff
(98.9 %id)
CB150233 Liver .k 1 to 560 1 to 560   tiling clone,   560/560
(100 %)
2 diff
(99.7 %id)
BP208926 cerebellum .k 25 to 607 1 to 583   tiling clone,   583/583
(100 %)
0 diff
(100 %id)
BP353202   .k 26 to 607 1 to 581       581/581
(100 %)
2 diff
(99.7 %id)
CB130546 Liver .k 27 to 313 1 to 287       287/287
(100 %)
2 diff
(99.4 %id)
BP256500 Kidney .k 28 to 598 1 to 571       571/571
(100 %)
3 diff
(99.5 %id)
BP365525 lung .k 32 to 612 1 to 583       583/583
(100 %)
4 diff
(99.4 %id)
BG749410 eye, normal pigmented retinal epithelium .k 37 to 733 1 to 706       706/715
(98 %)
23 diff
(96.8 %id)
BI766342 pooled lung and spleen .k 37 to 688 1 to 652       652/652
(100 %)
9 diff
(98.7 %id)
TI_57177561   .k 37 to 688 30 to 681       652/681
(95 %)
13 diff
(98.1 %id)
BM550079 astrocytoma grade IV, cell line, brain .k 48 to 970 28 to 962       935/1023
(91 %)
26 diff
(97.5 %id)
CR617225 Placenta Cot 25-normalized .k 49 to 1588 1 to 1540 exact tiling clone,   1540/1540
(100 %)
0 diff
(100 %id)
BX361494 Placenta Cot 25-normalized .k 49 to 885 1 to 837       837/910
(91 %)
12 diff
(98.7 %id)
AL554897 placenta, Placenta Cot 25-normalized .k 49 to 779 1 to 732   fully sequenced,   732/732
(100 %)
3 diff
(99.6 %id)
BM846653 myeloma .k 61 to 572 1 to 512       512/512
(100 %)
0 diff
(100 %id)
BF033227 adenocarcinoma, ovary .k 68 to 732 1 to 666       666/671
(99 %)
5 diff
(99.3 %id)
AW402179 lymph .k 83 to 447 8 to 373       366/373
(98 %)
8 diff
(97.9 %id)
TI_154138487   .k 83 to 504 75 to 497       423/515
(82 %)
10 diff
(98.1 %id)
BP347037 brain .k 92 to 671 1 to 580       580/582
(99 %)
6 diff
(99.0 %id)
DA912055   .k 94 to 668 2 to 576   capped   575/575
(100 %)
0 diff
(100 %id)
BE748432 bone marrow, from acute myelogenous leukemia .k 110 to 756 1 to 649       649/747
(86 %)
9 diff
(98.8 %id)
BX401134   .k 112 to 527 1 to 416       416/416
(100 %)
0 diff
(100 %id)
BP236577 coronary artery .k 123 to 704 1 to 583       583/583
(100 %)
3 diff
(99.5 %id)
BP253037 Kidney .k 123 to 711 1 to 589       589/589
(100 %)
0 diff
(100 %id)
AU099219   .k 123 to 422 1 to 300       300/300
(100 %)
0 diff
(100 %id)
BP253061 Kidney .k 123 to 691 1 to 569       569/569
(100 %)
0 diff
(100 %id)
BM789205 stomach .k 125 to 682 1 to 558       558/558
(100 %)
1 diff
(99.9 %id)
AL702332 human skeletal muscle .k 128 to 658 1 to 531       531/531
(100 %)
4 diff
(99.3 %id)
BM847023 myeloma .k 133 to 708 1 to 576       576/576
(100 %)
3 diff
(99.5 %id)
BP358575 mammary gland .k 137 to 719 1 to 582       582/582
(100 %)
5 diff
(99.2 %id)
BP354821   .k 141 to 722 1 to 582       582/582
(100 %)
1 diff
(99.9 %id)
BP356234   .k 141 to 723 1 to 583       583/583
(100 %)
0 diff
(100 %id)
CF140133 CNCAP(3)T-225 cell line, Prostate .k 149 to 266 8 to 125       118/126
(93 %)
7 diff
(94.5 %id)
BE391437 endometrium, adenocarcinoma cell line, uterus .k 160 to 1020 1 to 688       683/688
(99 %)
29 diff
(95.8 %id)
BU857779 adenocarcinoma, cell line, breast .k 160 to 986 1 to 833       833/883
(94 %)
7 diff
(99.3 %id)
CN258246 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .k 185 to 838 9 to 664       656/667
(98 %)
10 diff
(98.6 %id)
AL577507 placenta, Placenta Cot 25-normalized .k 718 to 1588 872 to 1   fully sequenced,   872/872
(100 %)
3 diff
(99.7 %id)
BX379315 Placenta Cot 25-normalized .l 1 to 921 1 to 920   tiling clone,   920/920
(100 %)
3 diff
(99.7 %id)
CR596193 Placenta Cot 25-normalized .l 62 to 1520 1 to 1459 exact     1459/1459
(100 %)
0 diff
(100 %id)
AL547277 placenta, Placenta Cot 25-normalized .l 62 to 763 1 to 702   fully sequenced,   702/702
(100 %)
0 diff
(100 %id)
TI_57233742   .l 67 to 851 9 to 791       783/791
(98 %)
8 diff
(99.0 %id)
BU786323 Pancreas, Purified pancreatic islet .l 68 to 705 1 to 638       638/638
(100 %)
4 diff
(99.4 %id)
TI_44342809   .l 69 to 837 119 to 888       770/888
(86 %)
9 diff
(99.0 %id)
CR590301 fetal brain .l 71 to 1522 1 to 1452 exact     1452/1452
(100 %)
0 diff
(100 %id)
AL537185 brain, fetal brain .l 71 to 847 1 to 777   fully sequenced,   777/777
(100 %)
0 diff
(100 %id)
NM_022821.2   .l 71 to 1552 1 to 1482 exact RefSeq, AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 1482/1482
(100 %)
0 diff
(100 %id)
DA966741 stomach .l 73 to 624 2 to 553   capped   552/552
(100 %)
0 diff
(100 %id)
CD050315 embryonic trophoblasts, made from WA01 stemcells .l 74 to 947 25 to 904       880/909
(96 %)
17 diff
(98.2 %id)
BP222848   .l 74 to 655 1 to 582       582/582
(100 %)
0 diff
(100 %id)
BI766443 pooled lung and spleen .l 74 to 984 1 to 906       906/908
(99 %)
13 diff
(98.6 %id)
DN601589 human embryonic stem cells .l 74 to 772 1 to 699       699/699
(100 %)
0 diff
(100 %id)
TI_57177605   .l 74 to 984 32 to 937       906/939
(96 %)
19 diff
(98.0 %id)
BP279474   .l 74 to 656 1 to 583       583/583
(100 %)
0 diff
(100 %id)
CB110528 Liver .l 74 to 505 1 to 432       432/432
(100 %)
0 diff
(100 %id)
DA541719 lung .l 75 to 663 2 to 590   capped   589/589
(100 %)
0 diff
(100 %id)
CB148892 Liver .l 76 to 757 1 to 682       682/682
(100 %)
0 diff
(100 %id)
TI_44346159   .l 77 to 920 75 to 919       845/919
(91 %)
17 diff
(98.2 %id)
BP339970 Spleen .l 77 to 656 1 to 580       580/580
(100 %)
0 diff
(100 %id)
DA964636 stomach .l 77 to 632 2 to 557   capped   556/556
(100 %)
0 diff
(100 %id)
TI_57218999   .l 78 to 917 62 to 904       843/904
(93 %)
14 diff
(98.5 %id)
TI_57150824   .l 78 to 970 23 to 919       897/919
(97 %)
16 diff
(98.3 %id)
CX164840 human embryonic stem cells differentiated toan early endodermal cell type .l 79 to 960 1 to 882       882/882
(100 %)
8 diff
(99.1 %id)
BP381620 adipose tissue .l 80 to 692 1 to 613       613/613
(100 %)
0 diff
(100 %id)
AK222498 adipose tissue .l 80 to 1552 1 to 1473 M201T AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 1473/1473
(100 %)
1 diff
(100.0 %id)
TI_57162592   .l 80 to 887 29 to 834       806/834
(96 %)
13 diff
(98.5 %id)
AF151846   .l 81 to 1552 1 to 1471 P189L V190W A191H Q192N Y194T ...     1471/1471
(100 %)
2 diff
(99.9 %id)
W03395 melanocyte .l 81 to 337 1 to 257       257/257
(100 %)
0 diff
(100 %id)
BI669113 brain, hypothalamus .l 82 to 920 1 to 839       839/839
(100 %)
15 diff
(98.3 %id)
TI_57148883   .l 83 to 816 1 to 735       735/736
(99 %)
8 diff
(99.0 %id)
BG469499 adenocarcinoma cell line, colon .l 84 to 963 1 to 881       881/885
(99 %)
12 diff
(98.7 %id)
BI761024 pooled colon, kidney, stomach .l 85 to 970 1 to 890       890/890
(100 %)
11 diff
(98.8 %id)
BI753883 brain .l 85 to 917 1 to 836       836/836
(100 %)
8 diff
(99.1 %id)
DR760295 embryonic stem .l 85 to 925 1 to 841       841/841
(100 %)
0 diff
(100 %id)
CB992919 placenta, pre-eclamptic placenta .l 85 to 891 28 to 839       812/840
(96 %)
18 diff
(97.9 %id)
CB994149 placenta, pre-eclamptic placenta .l 85 to 814 28 to 762       735/808
(90 %)
18 diff
(97.8 %id)
BI826651 brain, medulla .l 86 to 1007 1 to 923       923/927
(99 %)
8 diff
(99.2 %id)
TI_57174511   .l 86 to 1007 30 to 952       923/956
(96 %)
14 diff
(98.6 %id)
DB010291 colon, tumor tissue .l 86 to 639 2 to 555   capped   554/554
(100 %)
0 diff
(100 %id)
DA686004   .l 87 to 626 2 to 541   capped   540/540
(100 %)
0 diff
(100 %id)
CR616210 T cells (Jurkat cell line) Cot10-normalized .l 88 to 1521 1 to 1434 exact     1434/1434
(100 %)
0 diff
(100 %id)
CR623988 Placenta Cot 25-normalized .l 88 to 1522 1 to 1435 exact     1435/1435
(100 %)
0 diff
(100 %id)
AL549859 placenta, Placenta Cot 25-normalized .l 88 to 763 1 to 676   fully sequenced,   676/676
(100 %)
0 diff
(100 %id)
BX366943   .l 88 to 847 1 to 760   fully sequenced,   760/760
(100 %)
0 diff
(100 %id)
DT219140 brain .l 88 to 738 1 to 651       651/651
(100 %)
0 diff
(100 %id)
BP255911 Kidney .l 88 to 668 1 to 581       581/581
(100 %)
0 diff
(100 %id)
BP256951 Kidney .l 88 to 657 1 to 570       570/570
(100 %)
0 diff
(100 %id)
DA119786 cerebellum .l 89 to 639 2 to 552   capped   551/551
(100 %)
0 diff
(100 %id)
DA140027 alzheimer cortex .l 89 to 634 2 to 547   capped   546/546
(100 %)
0 diff
(100 %id)
DA356913 subthalamic nucleus .l 89 to 652 2 to 565   capped   564/564
(100 %)
0 diff
(100 %id)
DA357230 subthalamic nucleus .l 89 to 664 2 to 577   capped   576/576
(100 %)
0 diff
(100 %id)
DA357597 subthalamic nucleus .l 89 to 651 2 to 564   capped   563/563
(100 %)
0 diff
(100 %id)
DA363874 subthalamic nucleus .l 89 to 673 2 to 586   capped   585/585
(100 %)
0 diff
(100 %id)
DA368906 subthalamic nucleus .l 89 to 642 2 to 555   capped   554/554
(100 %)
0 diff
(100 %id)
CD672970 eye, Iris .l 89 to 504 1 to 416       416/416
(100 %)
0 diff
(100 %id)
BP252422 Kidney .l 89 to 669 1 to 581       581/581
(100 %)
0 diff
(100 %id)
DA906096   .l 89 to 344 2 to 257   capped   256/256
(100 %)
0 diff
(100 %id)
DA119194 cerebellum .l 91 to 626 2 to 537   capped   536/536
(100 %)
0 diff
(100 %id)
TI_44342681   .l 92 to 768 79 to 754       676/754
(89 %)
7 diff
(99.1 %id)
TI_44344752   .l 92 to 962 85 to 962       878/965
(90 %)
14 diff
(98.6 %id)
CR592943 placenta .l 94 to 1533 1 to 1440 exact     1440/1440
(100 %)
0 diff
(100 %id)
CR600869 Placenta Cot 25-normalized .l 94 to 1784 1 to 1691 exact tiling clone,   1691/1691
(100 %)
0 diff
(100 %id)
CR606895 Placenta Cot 25-normalized .l 94 to 1525 1 to 1432 exact     1432/1432
(100 %)
0 diff
(100 %id)
CR620696 Placenta Cot 25-normalized .l 94 to 1524 1 to 1431 exact     1431/1431
(100 %)
0 diff
(100 %id)
BX393888 Neuroblastoma Cot 25-normalized .l 94 to 360 1 to 267       267/267
(100 %)
0 diff
(100 %id)
AL541857 placenta .l 94 to 710 1 to 617   fully sequenced,   617/617
(100 %)
1 diff
(99.9 %id)
AL546903 placenta, Placenta Cot 25-normalized .l 94 to 940 1 to 847   fully sequenced,   847/847
(100 %)
1 diff
(99.9 %id)
AL549439 placenta, Placenta Cot 25-normalized .l 94 to 1027 1 to 928   fully sequenced,   928/928
(100 %)
1 diff
(99.9 %id)
AL551450 placenta, Placenta Cot 25-normalized .l 94 to 677 1 to 587   fully sequenced,   540/540
(100 %)
10 diff
(98.2 %id)
BM922051 pooled brain, lung, testis .l 94 to 979 12 to 904       893/999
(89 %)
24 diff
(97.6 %id)
TI_57181049   .l 94 to 816 65 to 786       722/811
(89 %)
11 diff
(98.7 %id)
BI668464 brain, hypothalamus .l 95 to 962 1 to 875       875/878
(99 %)
12 diff
(98.7 %id)
BP194969 brain .l 96 to 678 1 to 583       583/583
(100 %)
0 diff
(100 %id)
AF336793   .l 96 to 1552 1 to 1457 Y75H AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 1457/1457
(100 %)
3 diff
(99.8 %id)
AK001653   .l 96 to 1552 1 to 1457 S68P available from FLJ,   1457/1457
(100 %)
2 diff
(99.9 %id)
BU162905 ductal carcinoma, cell line, Pancreas .l 97 to 1065 1 to 994 Y194L L195P W196L W197V K198E ...     994/1071
(92 %)
41 diff
(96.2 %id)
BU185513 ductal carcinoma, cell line, Pancreas .l 97 to 962 1 to 872       872/874
(99 %)
9 diff
(99.0 %id)
BQ691434 ductal carcinoma, cell line, Pancreas .l 97 to 1038 1 to 944 K199S H200T M201*     944/945
(99 %)
11 diff
(98.9 %id)
CB987934 Human Placenta, placenta .l 97 to 811 28 to 746       719/747
(96 %)
13 diff
(98.3 %id)
AU132795   .l 97 to 977 2 to 886   capped   885/885
(100 %)
10 diff
(98.9 %id)
CR608264 Placenta Cot 25-normalized .l 99 to 1521 1 to 1423 exact     1423/1423
(100 %)
0 diff
(100 %id)
AL547935 placenta, Placenta Cot 25-normalized .l 99 to 604 1 to 506   fully sequenced,   506/506
(100 %)
0 diff
(100 %id)
BF308677 muscle, rhabdomyosarcoma .l 100 to 918 1 to 821       821/823
(99 %)
21 diff
(97.5 %id)
DA129764 alzheimer cortex .l 101 to 643 2 to 544   capped   543/543
(100 %)
0 diff
(100 %id)
BM556225 duodenal adenocarcinoma, cell line, small intestine .l 101 to 1082 1 to 988 F247V K257X K259S R260G L261C ...     988/1040
(95 %)
14 diff
(98.7 %id)
CR600285 B cells (Ramos cell line) Cot 25-normalized .l 102 to 1487 1 to 1386 exact     1386/1386
(100 %)
0 diff
(100 %id)
AL560594 B cells from Burkitt lymphoma .l 102 to 809 1 to 708   fully sequenced,   708/708
(100 %)
0 diff
(100 %id)
BU161349 melanotic melanoma, skin .l 102 to 895 1 to 804       804/821
(97 %)
10 diff
(98.8 %id)
BP263697 small intestine .l 103 to 685 1 to 583       583/583
(100 %)
0 diff
(100 %id)
BC000618 Kidney, renal cell adenocarcinoma .l 104 to 1552 1 to 1449 exact available from MGC, AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 1449/1452
(99 %)
1 diff
(100.0 %id)
TI_45211727   .l 104 to 909 87 to 896       810/952
(85 %)
21 diff
(97.8 %id)
BG386597 adenocarcinoma cell line, colon .l 105 to 1004 1 to 898       898/904
(99 %)
29 diff
(96.8 %id)
CV572529 cornea, eye .l 106 to 710 1 to 605       605/605
(100 %)
0 diff
(100 %id)
CR622911 Neuroblastoma Cot 25-normalized .l 109 to 1525 1 to 1417 exact     1417/1417
(100 %)
0 diff
(100 %id)
BQ920937 epidermoid carcinoma, cell line, lung .l 109 to 1002 1 to 904       904/904
(100 %)
24 diff
(97.4 %id)
DA133195 alzheimer cortex .l 112 to 653 2 to 543   capped   542/542
(100 %)
0 diff
(100 %id)
CA453919   .l 115 to 993 1 to 887       887/889
(99 %)
9 diff
(99.0 %id)
CA487492   .l 115 to 964 1 to 856       856/881
(97 %)
13 diff
(98.6 %id)
BQ218196 epithelioid carcinoma, Pancreas .l 118 to 951 1 to 840       840/959
(87 %)
19 diff
(98.1 %id)
BP383473   .l 120 to 618 1 to 499       499/499
(100 %)
0 diff
(100 %id)
CR624095 Placenta Cot 25-normalized .l 121 to 1553 1 to 1433 exact     1433/1433
(100 %)
0 diff
(100 %id)
BX366178 Placenta Cot 25-normalized .l 121 to 914 1 to 795       795/795
(100 %)
4 diff
(99.5 %id)
AK130174   .l 122 to 1552 1 to 1431 exact available from FLJ,   1431/1431
(100 %)
2 diff
(99.9 %id)
BG675381 skin .l 122 to 1039 1 to 924 V5*     924/943
(97 %)
46 diff
(95.2 %id)
BG740868 skin .l 132 to 986 1 to 861       861/862
(99 %)
13 diff
(98.5 %id)
DA617268   .l 134 to 714 2 to 582   capped   581/581
(100 %)
0 diff
(100 %id)
AL525354 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .l 136 to 762 28 to 654   fully sequenced,   627/654
(95 %)
6 diff
(99.1 %id)
BP262465 small intestine .l 147 to 728 1 to 582       582/582
(100 %)
0 diff
(100 %id)
BQ219583 epithelioid carcinoma, Pancreas .l 150 to 951 1 to 809       809/841
(96 %)
13 diff
(98.5 %id)
TI_57196748   .l 151 to 956 96 to 905       810/1019
(79 %)
13 diff
(98.8 %id)
BM546931 ovary (pool of 3) .l 153 to 1101 21 to 973 K257Q     953/1065
(89 %)
20 diff
(98.2 %id)
BX281698 ovary (pool of 3) .l 158 to 675 1 to 518       518/518
(100 %)
0 diff
(100 %id)
BM456499 lymph, lymphoma, cell line .l 195 to 1144 1 to 960 K199S H200T M201*     960/1063
(90 %)
28 diff
(97.4 %id)
ES314782 occipital scalp hair, skin .l 329 to 468 1 to 140       140/140
(100 %)
0 diff
(100 %id)
BG676210 skin, squamous cell carcinoma .l 341 to 898 1 to 558       558/558
(100 %)
0 diff
(100 %id)
BM543430 brain, hippocampus .l 348 to 1179 1 to 841       841/1036
(81 %)
27 diff
(97.4 %id)
CA487584   .l 413 to 1287 1 to 884       884/896
(98 %)
15 diff
(98.4 %id)
BG698902 skin .l 427 to 1309 1 to 867       867/867
(100 %)
18 diff
(98.0 %id)
CB216022 normal endometrium, late proliferativephase, cycle day 13, uterus .l 452 to 1072 1 to 621       621/621
(100 %)
0 diff
(100 %id)
CD631602   .l 467 to 1312 8 to 854       847/855
(99 %)
16 diff
(98.2 %id)
BG695923 skin .l 470 to 1360 1 to 875       875/875
(100 %)
24 diff
(97.3 %id)
BM764471 stomach .l 494 to 1193 1 to 699       699/699
(100 %)
1 diff
(99.9 %id)
BM772813 stomach .l 494 to 1074 1 to 581       581/581
(100 %)
0 diff
(100 %id)
BM772832 stomach .l 494 to 1157 1 to 664       664/664
(100 %)
0 diff
(100 %id)
BG743066 skin .l 502 to 1432 1 to 934       934/935
(99 %)
32 diff
(96.6 %id)
CD631606   .l 516 to 1271 765 to 9       757/770
(98 %)
9 diff
(98.9 %id)
BX398888 Placenta Cot 25-normalized .l 516 to 1512 998 to 1       998/1001
(99 %)
20 diff
(98.1 %id)
BU168866 melanotic melanoma, cell line, skin .l 534 to 1397 1 to 871       871/955
(91 %)
20 diff
(98.0 %id)
BG741701 skin .l 535 to 1379 1 to 852       852/855
(99 %)
14 diff
(98.4 %id)
AL572761 placenta, Placenta Cot 25-normalized .l 543 to 1521 976 to 1   fully sequenced,   976/976
(100 %)
3 diff
(99.7 %id)
BG742670 skin .l 574 to 1435 1 to 861       861/866
(99 %)
4 diff
(99.6 %id)
BQ334434 marrow .l 578 to 747 1 to 170       170/170
(100 %)
0 diff
(100 %id)
BG695951 skin .l 579 to 1410 1 to 838       838/840
(99 %)
16 diff
(98.1 %id)
CD631603   .l 585 to 1421 842 to 3       840/842
(99 %)
14 diff
(98.4 %id)
BG742899 skin .l 586 to 1329 1 to 743       743/743
(100 %)
1 diff
(99.9 %id)
CF455032 peripheral nervous system .l 643 to 1430 1 to 784       784/786
(99 %)
6 diff
(99.3 %id)
AL575013 placenta, Placenta Cot 25-normalized .l 647 to 1524 878 to 1   fully sequenced,   878/878
(100 %)
10 diff
(98.9 %id)
AL569137 placenta .l 649 to 1455 883 to 79   fully sequenced,   805/883
(91 %)
12 diff
(98.7 %id)
AL525312 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .l 732 to 1525 793 to 1   fully sequenced,   793/793
(100 %)
15 diff
(98.2 %id)
AL572278 placenta, Placenta Cot 25-normalized .l 733 to 1511 787 to 10   fully sequenced,   778/787
(98 %)
2 diff
(99.8 %id)
AL573892 placenta, Placenta Cot 25-normalized .l 733 to 1522 792 to 1   fully sequenced,   792/792
(100 %)
9 diff
(98.9 %id)
AL582006 B cells from Burkitt lymphoma .l 779 to 1479 709 to 9   fully sequenced,   701/709
(98 %)
0 diff
(100 %id)
AL566696 brain, fetal brain .l 786 to 1506 727 to 14   fully sequenced,   714/727
(98 %)
0 diff
(100 %id)
BX366942   .l 786 to 1517 736 to 5   fully sequenced,   732/736
(99 %)
0 diff
(100 %id)
AL572069 placenta, Placenta Cot 25-normalized .l 910 to 1784 873 to 1   fully sequenced,   873/873
(100 %)
6 diff
(99.4 %id)
BX379314 Placenta Cot 25-normalized .l 973 to 1499 527 to 1       527/537
(98 %)
8 diff
(98.6 %id)
AL573737 placenta, Placenta Cot 25-normalized .l 997 to 1519 527 to 7   fully sequenced,   521/527
(98 %)
15 diff
(97.2 %id)
AU154254   .l 1023 to 1552 528 to 1       528/528
(100 %)
8 diff
(98.5 %id)
N67811 melanocyte .l 1080 to 1547 470 to 1       470/470
(100 %)
2 diff
(99.6 %id)
BU784596 Pancreas, Purified pancreatic islet .l 1128 to 1553 429 to 4       426/429
(99 %)
0 diff
(100 %id)
BP302780   .m 1 to 611 1 to 611 F181X S184X K185Q Q203X tiling clone,   611/611
(100 %)
2 diff
(99.7 %id)
CR978901 T-Lymphocytes .n 1 to 820 5 to 826 W154V V156G I158D A159C G162R ... tiling clone,   826/827
(99 %)
5 diff
(99.4 %id)
BM010667 amelanotic melanoma, cell line, skin .o 1 to 611 2 to 618       618/618
(100 %)
10 diff
(98.4 %id)
BM556982 amelanotic melanoma, cell line, skin .o 1 to 955 1 to 969 K196X A197G N198H tiling clone,   969/1036
(93 %)
21 diff
(98.0 %id)
TI_59385512   .o 1 to 611 59 to 675       617/617
(100 %)
9 diff
(98.6 %id)
CB113308 Liver .o 3 to 272 1 to 270       270/270
(100 %)
0 diff
(100 %id)
CD110051 Human Placenta, placenta .o 8 to 725 26 to 749       724/768
(94 %)
13 diff
(98.4 %id)
CF134704 CNCAP(3)T-225 cell line, Prostate .o 10 to 583 1 to 573       573/573
(100 %)
6 diff
(99.0 %id)
CB145139 Liver .o 10 to 227 1 to 219       219/219
(100 %)
6 diff
(97.3 %id)
CB142634 Liver .o 11 to 387 1 to 377       377/377
(100 %)
3 diff
(99.3 %id)
CN258247 embryonic stem cells, cell lines H1, H7, andH9 .o 13 to 547 13 to 547       535/547
(97 %)
6 diff
(99.0 %id)
BQ225203 epithelioid carcinoma, Pancreas .o 15 to 810 1 to 805 V150A F163L L165P Y171D K176Q ... tiling clone,   805/869
(92 %)
36 diff
(95.9 %id)
TI_154162778   .o 15 to 789 78 to 854 K76R I77L A78P P79R G80E ... tiling clone,   777/1105
(70 %)
31 diff
(97.2 %id)
CN258249 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .o 19 to 371 1 to 353       353/353
(100 %)
0 diff
(100 %id)
CB128729 Liver .o 39 to 690 1 to 652       652/652
(100 %)
1 diff
(99.9 %id)
CN258254 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .o 55 to 406 12 to 363       352/363
(96 %)
6 diff
(98.4 %id)
BM472630 melanotic melanoma, skin .p-u 1 to 545 1 to 547 E169G G170R R171E R172T S173E ... tiling clone,   547/1090
(50 %)
5 diff
(99.6 %id)
BE767986 prostate_tumor .q 1 to 334 340 to 10   tiling clone,   331/340
(97 %)
0 diff
(100 %id)
AW948828 prostate_tumor .q 80 to 349 270 to 1   tiling clone, Submitted on the opposite strand 270/270
(100 %)
2 diff
(99.3 %id)
BE768100 prostate_tumor .q 107 to 354 263 to 12       252/266
(94 %)
0 diff
(100 %id)
DN995209 brain, whole brain .q 256 to 1099 21 to 865 G130X P162A S163K G164W I165N ... tiling clone,   845/865
(97 %)
10 diff
(98.9 %id)
BF901472 marrow .q 293 to 746 1 to 454       454/454
(100 %)
5 diff
(98.9 %id)
BC095456 Chondrosarcoma Lung Metastasis .r 1 to 1383 6 to 1388 exact tiling clone, AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 1388/1388
(100 %)
0 diff
(100 %id)
CF127830 Chondrosarcoma Lung Metastasis cell lines, lung .r 1 to 781 6 to 784 exact     784/784
(100 %)
2 diff
(99.8 %id)
TI_154193514   .r 1 to 843 55 to 888 exact     839/989
(84 %)
11 diff
(98.9 %id)
BI261425 lymph, lymphoma, cell line .r 347 to 1029 1 to 681       681/681
(100 %)
9 diff
(98.7 %id)
H56555 liver and spleen .r 370 to 837 7 to 488       482/490
(98 %)
30 diff
(93.9 %id)
H56556 liver and spleen .r 891 to 1361 489 to 1       489/489
(100 %)
17 diff
(96.6 %id)
BU183065 melanotic melanoma, skin .s 1 to 732 2 to 737 W153X W154X V156G K157V I158K ... tiling clone,   737/895
(82 %)
6 diff
(99.4 %id)
DA358240 subthalamic nucleus .s 8 to 584 2 to 582   capped   581/581
(100 %)
4 diff
(99.4 %id)
DB479828 hippocampus .s 32 to 525 1 to 496       496/496
(100 %)
3 diff
(99.4 %id)
BM794005 Ascites, stomach .t 1 to 558 1 to 558   tiling clone,   558/558
(100 %)
0 diff
(100 %id)
CN258250 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .t 44 to 501 10 to 467       458/467
(98 %)
6 diff
(98.8 %id)
BP355006   .t 103 to 684 1 to 583 A104G L105T R106* tiling clone,   583/583
(100 %)
3 diff
(99.5 %id)
DT218868 brain .t 602 to 1236 1 to 635   tiling clone,   635/635
(100 %)
0 diff
(100 %id)
BF766840 colon_est .t 625 to 853 249 to 23     Submitted on the opposite strand 227/250
(90 %)
0 diff
(100 %id)
BF766841 colon_est .t 625 to 873 249 to 2     Submitted on the opposite strand 248/250
(99 %)
0 diff
(100 %id)
BG108027 Bone, osteosarcoma, cell line .t 923 to 1326 1 to 404       404/404
(100 %)
0 diff
(100 %id)
BM793898 Ascites, stomach .t 931 to 1537 1 to 607       607/607
(100 %)
0 diff
(100 %id)
BU846013 ovary, teratocarcinoma, cell line .t 963 to 1770 839 to 21   AAA Submitted on the opposite strand 817/958
(85 %)
23 diff
(97.6 %id)
BX351973 Placenta Cot 25-normalized .t 973 to 1771 798 to 1       798/891
(89 %)
37 diff
(95.9 %id)
TI_154093437   .t 977 to 1771 915 to 126       790/1104
(71 %)
4 diff
(99.7 %id)
BQ018168 lung, Metastatic Chondrosarcoma .t 1008 to 1770 781 to 19   tiling clone, AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 763/763
(100 %)
0 diff
(100 %id)
BU629141 cell lines, Chondrosarcoma .t 1014 to 1765 769 to 19   AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 751/751
(100 %)
2 diff
(99.8 %id)
AW875455 pnet .t 1022 to 1145 124 to 1       124/124
(100 %)
0 diff
(100 %id)
CA308147 Alveolar Macrophage, lung .t 1026 to 1765 756 to 19   AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 738/738
(100 %)
3 diff
(99.6 %id)
BM452643 lymph, lymphoma, cell line .u-u 1 to 843 1 to 847 G63X G105X V107G S112F W113L ... tiling clone,   847/1076
(78 %)
24 diff
(97.8 %id)
DB263956 uterus .va 1 to 589 2 to 590   tiling clone, capped   589/589
(100 %)
1 diff
(99.9 %id)
DB050566 testis .va 48 to 610 2 to 564   capped   563/563
(100 %)
1 diff
(99.9 %id)
DA425207 colon .va 50 to 607 2 to 559   capped   558/558
(100 %)
1 diff
(99.9 %id)
DA554447   .va 53 to 596 2 to 545   capped   544/544
(100 %)
1 diff
(99.9 %id)
DA947627 Spleen .va 110 to 662 2 to 554   tiling clone, capped   553/553
(100 %)
1 diff
(99.9 %id)
AA482657.
matches multiple genes
ovarian tumor, ovary .va 324 to 717 1 to 394     also hits gene CCDC86 394/394
(100 %)
0 diff
(100 %id)
AW963553   .va 569 to 1026 1 to 459 V102G I104D A105S tiling clone,   459/567
(80 %)
6 diff
(99.0 %id)
CA311642 Human Lung Epithelial cells, lung .vb-u 203 to 922 738 to 19   tiling clone, AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 720/720
(100 %)
2 diff
(99.8 %id)
AA477728 ovarian tumor, ovary .vb-u 206 to 573 1 to 367   fully sequenced,   367/367
(100 %)
0 diff
(100 %id)
TI_149292519   .vb-u 222 to 922 784 to 84   tiling clone, AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 701/702
(99 %)
0 diff
(100 %id)
BM852566 stomach .vb-u 228 to 656 1 to 429       429/429
(100 %)
0 diff
(100 %id)
BM850795 stomach .vb-u 228 to 754 1 to 527       527/527
(100 %)
0 diff
(100 %id)
TI_149309172   .vb-u 232 to 917 778 to 93   AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 686/946
(72 %)
0 diff
(100 %id)
BU687589 lung .vb-u 232 to 917 704 to 19   AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 686/694
(98 %)
0 diff
(100 %id)
TI_154016997   .vb-u 236 to 923 790 to 101       690/800
(86 %)
0 diff
(100 %id)
BM974606 lung .vb-u 242 to 922 699 to 19   AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 681/681
(100 %)
0 diff
(100 %id)
BU149457 melanotic melanoma, cell line, skin .vb-u 263 to 922 1 to 660   AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 660/660
(100 %)
0 diff
(100 %id)
BQ877990 melanotic melanoma, cell line, skin .vb-u 263 to 922 1 to 660   AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 660/660
(100 %)
0 diff
(100 %id)
BQ679136 melanotic melanoma, cell line, skin .vb-u 263 to 922 1 to 660   AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 660/660
(100 %)
0 diff
(100 %id)
BQ683584 melanotic melanoma, cell line, skin .vb-u 263 to 922 1 to 660   AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 660/660
(100 %)
0 diff
(100 %id)
BQ682483 melanotic melanoma, cell line, skin .vb-u 263 to 924 1 to 662 exact tiling clone, AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 662/662
(100 %)
0 diff
(100 %id)
BU185937 melanotic melanoma, cell line, skin .vb-u 263 to 922 1 to 660   AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 660/660
(100 %)
0 diff
(100 %id)
BU180063 melanotic melanoma, cell line, skin .vb-u 263 to 922 1 to 660   AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 660/660
(100 %)
0 diff
(100 %id)
BQ678430 melanotic melanoma, cell line, skin .vb-u 263 to 922 1 to 660   AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 660/660
(100 %)
0 diff
(100 %id)
BI762591 pooled colon, kidney, stomach .vb-u 277 to 912 1 to 636       636/636
(100 %)
0 diff
(100 %id)
BM764500 Ascites, stomach .vb-u 281 to 840 1 to 560       560/560
(100 %)
0 diff
(100 %id)
BQ228100 epithelioid carcinoma, Pancreas .vb-u 289 to 922 1 to 634   AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 634/634
(100 %)
0 diff
(100 %id)
BQ445875 Knee, Osteoarthritic Cartilage .vb-u 297 to 922 644 to 19   AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 626/636
(98 %)
0 diff
(100 %id)
BQ014230 Chondrosarcoma, Left Pubic Bone .vb-u 300 to 917 636 to 19   AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 618/618
(100 %)
0 diff
(100 %id)
BQ187372 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .vb-u 311 to 922 1 to 612   fully sequenced, AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 612/612
(100 %)
1 diff
(99.9 %id)
TI_151734353   .vb-u 311 to 922 698 to 87   AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 612/970
(63 %)
0 diff
(100 %id)
N47641 multiple sclerosis lesions .vb-u 367 to 635 1 to 273   fully sequenced,   273/273
(100 %)
0 diff
(100 %id)
DB570458 hypothalamus .vb-u 412 to 922 1 to 511     Submitted on the opposite strand 511/511
(100 %)
0 diff
(100 %id)
BQ187598 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .vb-u 427 to 917 1 to 491   fully sequenced, AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 491/491
(100 %)
0 diff
(100 %id)
AI978735 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .vb-u 458 to 922 465 to 1       465/465
(100 %)
0 diff
(100 %id)
AI554778 anaplastic oligodendroglioma, brain .vb-u 462 to 922 461 to 1       461/461
(100 %)
0 diff
(100 %id)
DB564673 hypothalamus .vb-u 466 to 922 1 to 457     Submitted on the opposite strand 457/457
(100 %)
0 diff
(100 %id)
BU180089 melanotic melanoma, cell line, skin .vb-u 491 to 922 1 to 432   AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 432/435
(99 %)
1 diff
(99.8 %id)
AI281836 colon, moderately-differentiated adenocarcinoma .vb-u 533 to 919 387 to 1       387/387
(100 %)
0 diff
(100 %id)
AI201683 anaplastic oligodendroglioma, brain .vb-u 539 to 917 379 to 1       379/379
(100 %)
0 diff
(100 %id)
AA477729 ovarian tumor, ovary .vb-u 543 to 923 381 to 1   fully sequenced,   381/381
(100 %)
0 diff
(100 %id)
CK300687 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .vb-u 566 to 922 375 to 19   fully sequenced, AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 357/357
(100 %)
0 diff
(100 %id)
AW516411 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .vb-u 601 to 923 323 to 1       323/323
(100 %)
0 diff
(100 %id)
N57496 multiple sclerosis lesions .vb-u 605 to 922 319 to 1   fully sequenced,   319/319
(100 %)
0 diff
(100 %id)
BQ184502 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .vb-u 644 to 917 292 to 19   fully sequenced, AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 274/274
(100 %)
0 diff
(100 %id)
EC483319 Prostate .vb-u 852 to 923 1 to 72       72/72
(100 %)
0 diff
(100 %id)
DA001770   .vc 1 to 567 2 to 569 R51L R52Q S53I D55G P56S ... tiling clone, capped   566/568
(99 %)
3 diff
(99.5 %id)
BI766955 pooled lung and spleen .vc 45 to 824 1 to 788   tiling clone,   788/788
(100 %)
15 diff
(98.1 %id)
TI_57178689   .vc 45 to 824 35 to 823       789/823
(95 %)
19 diff
(97.7 %id)
AA380705   .vc 318 to 579 1 to 262       262/262
(100 %)
1 diff
(99.7 %id)
BE175287 head_neck .vc 329 to 661 362 to 33   tiling clone, Submitted on the opposite strand 330/362
(91 %)
1 diff
(99.8 %id)
AA248207   .vd 1 to 239 1 to 240 R57P R63P E66* tiling clone,   240/241
(99 %)
8 diff
(96.7 %id)
CN258253 embryonic stem cells, DMSO-treated H9 cellline .ve 1 to 412 1 to 412   tiling clone,   412/412
(100 %)
1 diff
(99.8 %id)
BG743842 skin .ve 189 to 842 29 to 683 exact tiling clone,   655/683
(95 %)
7 diff
(99.0 %id)
CN267482 embryonic stem cells, cell lines H1, H7, andH9 .vf-u 1 to 572 1 to 573 L51A F52V R53P N54* tiling clone,   573/573
(100 %)
8 diff
(98.7 %id)
BI013802 lung_tumor .vg-u 1 to 425 29 to 453 K39N T40D L41A S42I T43H ... tiling clone,   425/464
(91 %)
9 diff
(98.1 %id)
BI013813 lung_tumor .vg-u 1 to 201 8 to 215       208/256
(81 %)
13 diff
(95.0 %id)
CB137002 Liver .vh 1 to 417 1 to 418 exact tiling clone,   418/418
(100 %)
1 diff
(99.8 %id)
BF842658 head_neck Gene MED8andELOVL1, variant not shown              
147 other accessions, mainly redundant or of lesser quality, also belong to this gene but are not reported.
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h, .i, .j, .k, .l, .m, .n, .o, .p-u, .q, .r, .s, .t, .u-u, .va, .vb-u, .vc, .vd, .ve, .vf-u, .vg-u, .vh Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes CI